Loading clinical trials...
Loading clinical trials...
Intravenous Immunoglobulin (IVIG) Treatment in Children With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS): an Open-label Trial in South-western Sweden
Conditions
Interventions
Privigen Injectable Product (Intravenous Immunoglobulin)
Locations
1
Sweden
Gillberg Neuropsychiatry Centre
Gothenburg, Sweden
Start Date
January 12, 2021
Primary Completion Date
October 15, 2025
Completion Date
October 15, 2025
Last Updated
March 6, 2026
Lead Sponsor
Göteborg University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions